ApprovalTrail

Approval · Notice of Compliance 1284 · 2000

FLAGYL: Notice of Compliance 1284

Issued October 27, 2000

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1284
Date
October 27, 2000
Company
Aventis Pharma Inc.Laval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Antibacterial - antiprotozoal

Products in this notice

BrandDINStatus today
FLAGYL01926888Cancelled Post Market
FLAGYL01926853Cancelled Pre Market
FLAGYL01926861Cancelled Post Market

Medicinal ingredients